{"entity":{"type":"insider","cik":"0001432680","url":"/insider/0001432680","json_url":"/insider/0001432680.json","name":"Nordic Biotech General Partner ApS","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":4,"n_filings":4,"first":"2008-04-21","last":"2010-06-11","span_basis":"filed_date"},"name_variants":[{"name":"Nordic Biotech General Partner ApS","source":"filing","n_filings":3,"first_seen":"2010-01-11","last_seen":"2010-06-11"},{"name":"Nordic Biotech Advisors ApS","source":"filing","n_filings":1,"first_seen":"2008-04-21","last_seen":"2008-04-21"}],"transactions":[{"id":7766352,"accession":"0001455244-10-000107","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001455244-10-000107","line_url":"/filing/0001455244-10-000107#line-1","is_derivative":false,"issuer_cik":"0001278129","issuer_name":"Osteologix, Inc.","issuer_ticker":"OLGXOB","issuer_name_source":null,"issuer_url":"/issuer/0001278129","owner_cik":null,"owner_name":"Nordic Biotech General Partner ApS; Nordic Biotech Opportunity Fund K/S; Nordic Biotech K/S","owner_display_name":"Nordic Biotech General Partner ApS","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock, par value $0.0001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1494532.0,"shares_display":"1,494,532","price_per_share":0.5018,"price_display":"0.50","price_state":"stated","total_value":749956.1576,"total_display":"749,956.16","total_whole":"749,956","shares_owned_after":6517264.0,"shares_owned_after_display":"6,517,264","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-06-11","filed_date":"2010-06-11","scope":"insider"},{"id":9289117,"accession":"0001455244-10-000026","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001455244-10-000026","line_url":"/filing/0001455244-10-000026#line-1","is_derivative":false,"issuer_cik":"0001360542","issuer_name":"Osteologix, Inc.","issuer_ticker":"OLGX OB","issuer_name_source":null,"issuer_url":"/issuer/0001360542","owner_cik":null,"owner_name":"Nordic Biotech General Partner ApS; Nordic Biotech K/S; Nordic Biotech Opportunity Fund K/S","owner_display_name":"Nordic Biotech General Partner ApS","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock, par value $0.0001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1992428.0,"shares_display":"1,992,428","price_per_share":0.5019,"price_display":"0.50","price_state":"stated","total_value":999999.6132,"total_display":"999,999.61","total_whole":"1,000,000","shares_owned_after":5022732.0,"shares_owned_after_display":"5,022,732","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-01-07","filed_date":"2010-01-12","scope":"insider"},{"id":7454565,"accession":"0001455244-10-000022","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001455244-10-000022","line_url":"/filing/0001455244-10-000022#line-1","is_derivative":false,"issuer_cik":"0001278129","issuer_name":"Osteologix, Inc.","issuer_ticker":"OLGXOB","issuer_name_source":null,"issuer_url":"/issuer/0001278129","owner_cik":null,"owner_name":"Nordic Biotech Opportunity Fund K/S; Nordic Biotech K/S; Nordic Biotech General Partner ApS","owner_display_name":"Nordic Biotech Opportunity Fund K/S","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock, par value $0.0001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1992428.0,"shares_display":"1,992,428","price_per_share":0.0519,"price_display":"0.05","price_state":"stated","total_value":103407.0132,"total_display":"103,407.01","total_whole":"103,407","shares_owned_after":5022732.0,"shares_owned_after_display":"5,022,732","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-01-07","filed_date":"2010-01-11","scope":"insider"},{"id":3405545,"accession":"0001144204-08-023451","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-08-023451","line_url":"/filing/0001144204-08-023451#line-1","is_derivative":false,"issuer_cik":"0001278129","issuer_name":"Osteologix, Inc.","issuer_ticker":"OLGX.OB","issuer_name_source":null,"issuer_url":"/issuer/0001278129","owner_cik":"0001432680","owner_name":"Nordic Biotech Advisors ApS","owner_display_name":"Nordic Biotech Advisors ApS","owner_url":"/insider/0001432680","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.0001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3030304.0,"shares_display":"3,030,304","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":18163365.0,"shares_owned_after_display":"18,163,365","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-04-17","filed_date":"2008-04-21","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":1,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":1},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001278129","name":"Osteologix, Inc.","url":"/issuer/0001278129","role":"Ten percent owner","n_filings":4,"first_seen":"2008-04-21","last_seen":"2010-06-11"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001432680","retrieved_at":"2026-08-24T21:21:52+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}